Strong biopharmaceutical sales, temperature sensitivity, biosimilar launches and increasing outsourcing trends are expected to be the catalysts in driving the global biopharmaceutical logistics market in the coming years. Research firm IMARC Group expects this market to experience double digit growth rates during 2014-2018, according to its latest report titled “Global Healthcare Cold Chain Logistics Market Report & Forecast: 2013-2018”. The report which has done a comprehensive analysis on the cold chain requirements and opportunities for healthcare products expects the global biopharmaceutical market to reach sales worth USD 177 billion by 2018, creating a huge demand for cold chain logistic services.
According to an analyst at IMARC Group, “Outsourcing trends in the biopharmaceutical industry are increasing with more and more manufacturers outsourcing the manufacturing of their drugs to third parties. The trends in outsourcing are expected to increase even further among smaller biopharmaceutical companies who typically find that biopharmaceutical manufacturing and process development are not a part of their existing core competencies. The increasing trends in biopharmaceutical outsourcing creates an additional step in the overall supply chain of these drugs. In many cases, contract manufacturers and their partners may be present in two different countries; this creates huge requirements for the efficient cold chain packaging, storage and transportation of drugs between the pharmaceutical company and its contract manufacturer”.
IMARC’s new report entitled “Global Healthcare Cold Chain Logistics Market Report & Forecast (2013-2018)”, which is the third edition of our highly acclaimed publication, provides a comprehensive insight into the logistic opportunities in the global healthcare market. The study, that has been undertaken using both desk based and qualitative primary market research, has analyzed three aspects of the global healthcare cold chain logistics market.
The first aspect involves the quantification of the global market for temperature sensitive healthcare products into three major classes and evaluation of the current and future opportunities in each of these classes. The second aspect involves an in-depth understanding on the global healthcare cold chain distribution process and logistic requirements for various temperature sensitive healthcare products. The third aspect involves the quantification of the global healthcare cold chain logistic services market and a comprehensive evaluation of its various segments.
What we have achieved in this report:
Comprehensive Market Analysis of Temperature Sensitive Healthcare Products:
Classes Covered: Biopharmaceuticals, Vaccines and Clinical Trial Materials
Focus of the Analysis in Each Class:
Understanding the Operations of a Healthcare Cold Chain Distribution Process
Focus of the Analysis:
Comprehensive Market Analysis of the Healthcare Cold Chain Logistic Services Market
Focus of the analysis:
Information Sources:
Information has been sourced from both primary and secondary sources:
To buy the complete report or to get a free sample, please contact:
IMARC Group North America
Email: america@imarcgroup.com
Phone: +1-631-791-1145
IMARC Group Europe, Middle East & Africa
Email: ema@imarcgroup.com
Phone: +44-702-409-7331
To know more please visit: https://www.imarcgroup.com/healthcare-cold-chain-logistics-market